🇺🇸 FDA
Patent

US 10052393

Multifunctional nanomaterials for the treatment of cancer

granted A61KA61K33/242A61K33/243

Quick answer

US patent 10052393 (Multifunctional nanomaterials for the treatment of cancer) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K33/242, A61K33/243, A61K33/244, A61K41/0052